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BACKGROUND Diabetes mellitus (DM) is known to be a risk factor of
signiﬁcant coronary artery disease (CAD). However, there is no
currently available data with larger study population regarding long-
term clinical outcomes of DM with CAS in real world clinical practice,
particularly in a series of Korean population.
METHODS A total of 3,360 consecutive patients (pts) without signiﬁ-
cant CAD underwent acetylcholine (Ach) provocation test and diag-
nosed as signiﬁcant CAS between Nov. 2004 and May. 2014 were
enrolled. Signiﬁcant CAS was deﬁned as >70% of narrowing by in-
cremental intracoronary injection of 20, 50 and 100 mg into left coro-
nary artery. Patients were divided into two groups based on the
presence of DM: the DM group (n¼568), the non- DM group (n¼2,762).
To adjust potential confounders, a propensity score matched (PSM)
analysis was performed using the logistic regression model. Major
clinical outcomes up to 5 years were compared between the two
groups.
RESULTS After PSM analysis, 2 propensity-matched groups (561pairs,
n ¼ 1122, C-statistic¼0.690) were generated and the baseline charac-
teristics of the two groups were balanced. At 5 years, despite of similar
incidence of individual hard endpoints including mortality, myocar-
dial infarction and revascularization, the DM group was associated
with lower incidence of recurrent angina requiring repeat coronary
angiography than the non-DM group (HR; 0.60, 95% C.I; 0.40-0.90,
p¼0.014, Table and Figure).
CONCLUSION Despite the expected endothelial dysfunction, DM was
negatively associated with CAS and recurrent chest pain, suggesting
that the mechanisms and risk factors of CAS may be different from
those of CAD.TCTAP A-154
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BACKGROUND There is a lack of data regarding the outcomes of
medical treatment for stable coronary artery disease (SCAD) involving
unprotected left main coronary artery (ULMCA) stenosis.
METHODS From March, 1992 to February, 2011, a total of 3041 patients
with signiﬁcant ULMCA stenosis were enrolled in ASAN-MAIN regis-
try. After excluding the patients in unstable clinical conditions
(N ¼ 342), we analyzed those who declined any revascularizationprocedures (N¼153), despite of their assigned physicians’ prediction of
an acceptable degree of peri-procedural risks and the severity of
ULMCA stenosis compelling revascularization, compared with those
who underwent percutaneous coronary intervention (PCI, N¼993),
and coronary artery bypass grafting (CABG, N¼1372).
RESULTS The rates of 2-year follow-up were 83.3%, 86.5%, and 66.7%
in the PCI, CABG, and non-revascularization groups, respectively
(p<0.001). The patients enrolled in the CABG, and the non-revascu-
larization groups were older (PCI vs. CABG vs. Non-revascularization,
60.811.2 vs. 63.49.1 vs. 66.310.9, p < 0.001), and more likely to
have lower ejection fraction (61.27.6 vs. 57.211 vs. 57.912.2,
p<0.001) diabetes (PCI; 31.6%, CABG; 37.6%, Non-revascularization;
36.6%) than the PCI group. Furthermore, other clinical and angio-
graphic risk factors were more prevalent in these groups, such as
diabetes, congestive heart failure, peripheral vascular disease, multi-
vessel disease, distal bifurcation involvement, and right coronary ar-
tery disease. The crude 2-year rates of MACCE (PCI, 5.9%; CABG, 8.3%;
Non-revascularization, 28.0%; p among the three groups < 0.001) and
all of the individual outcomes were higher in the medication group
than the others, except for that of stroke showing insigniﬁcant dif-
ference. Multivariate Cox’s proportional hazards model revealed that
Non-revascularization was an independent predictor of MACCE
(Hazard Ratio [HR], 0.362; 95% Conﬁdence Interval [CI], 0.205 – 0.639;
p value < 0.001 for PCI vs. Non-revascularization, HR, 0.376; 95% CI,
0.225 – 0.629; p value < 0.001 for CABG vs. Non-revascularization).
CONCLUSION Although clinical presentation was stable, non revas-
cularized ULMCA stenosis was associated with the higher mortality.TCTAP A-155
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BACKGROUND Cyclophilin A (CyPA), secreted by vascular smooth
muscle cells in response to oxidative stress, is important in the
pathogenesis of progressive peripheral arterial occlusion disease
(PAOD), which is common among chronic kidney disease. We
explored the prevalence of PAOD in Taiwan’s elderly (3 65 years old)
population and its association with CyPA and renal function.
METHODS Residents of Tianliao District, a rural community in
southern Taiwan, were surveyed. Anankle-brachial index (ABI) < 0.91
was deﬁned as PAOD. Chronic kidney disease (CKD) was deﬁned
based on eGFR levels < 60 mL/min/1.73m2. Serum CyPA was measured
by ELISA.
RESULTS Of the 473 participants, 68 (14.4%) had PAOD. The lower
eGFR, lower BMI, higher glycated hemoglobin, and higher pulse
pressure were independent predictors of ABI <0.91. Serum CyPA
levels in participants with PAOD were signiﬁcantly higher than those
with normal ABI values (47.3  0.4 vs. 25.5  0.2 ng/mL, p <0.001).
Moreover, eGFR inversely correlated with serum CyPA level (p < 0.05)
in participants with CKD, but not in participants with normal renal
function.
